TEHRAN – Iranian researchers at Royan Institute, in collaboration with researchers from Germany’s University of Duisburg-Essen, have developed namiRa (meaning “immortal” in Persian), a comprehensive and specialized database that serves as a valuable scientific infrastructure that facilitates the identification of novel cancer biomarkers, accelerates the discovery of therapeutic targets, and supports the design of future cancer research.
Iranian Researchers Develop Comprehensive MicroRNA Database for Cancer Research
Iranian researchers at Royan Institute, in collaboration with Germany's University of Duisburg-Essen, have developed namiRa, a specialized microRNA database aimed at advancing cancer research. This initiative enhances Iran's scientific infrastructure and positions it as a contributor to global cancer research efforts.
👥 Key Players
📰 What Happened
Iranian researchers have developed a new microRNA database called namiRa to aid in cancer research. This database aims to facilitate the identification of cancer biomarkers and support therapeutic target discovery.
- The database is named 'namiRa', which means 'immortal' in Persian.
- The project is a collaboration between Iranian and German researchers.
💡 Why It Matters
📚 Background
MicroRNAs are small non-coding RNA molecules that play crucial roles in regulating gene expression and are important in cancer biology. Developing databases for such research can lead to breakthroughs in cancer treatment.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%